UBS Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.7K | Sell |
7,532
-65,276
| -90% | -$725K | ﹤0.01% | 6111 |
|
|
2025
Q1 | $1.02M | Buy |
72,808
+55,692
| +325% | +$780K | ﹤0.01% | 4184 |
|
|
2024
Q4 | $284K | Buy |
17,116
+15,396
| +895% | +$256K | ﹤0.01% | 5049 |
|
|
2024
Q3 | $32.5K | Sell |
1,720
-8,316
| -83% | -$157K | ﹤0.01% | 5887 |
|
|
2024
Q2 | $145K | Buy |
10,036
+4,738
| +89% | +$68.6K | ﹤0.01% | 4771 |
|
|
2024
Q1 | $82K | Buy |
5,298
+4,895
| +1,215% | +$75.8K | ﹤0.01% | 5149 |
|
|
2023
Q4 | $11.3K | Sell |
403
-7,904
| -95% | -$221K | ﹤0.01% | 6191 |
|
|
2023
Q3 | $395K | Buy |
8,307
+4,645
| +127% | +$221K | ﹤0.01% | 3777 |
|
|
2023
Q2 | $351K | Sell |
3,662
-1,843
| -33% | -$177K | ﹤0.01% | 4089 |
|
|
2023
Q1 | $624K | Sell |
5,505
-5,557
| -50% | -$630K | ﹤0.01% | 3552 |
|
|
2022
Q4 | $1.24M | Buy |
11,062
+9,273
| +518% | +$1.04M | ﹤0.01% | 2963 |
|
|
2022
Q3 | $229K | Buy |
1,789
+1,608
| +888% | +$206K | ﹤0.01% | 3956 |
|
|
2022
Q2 | $12K | Sell |
181
-4,509
| -96% | -$299K | ﹤0.01% | 6628 |
|
|
2022
Q1 | $668K | Buy |
4,690
+4,457
| +1,913% | +$635K | ﹤0.01% | 3558 |
|
|
2021
Q4 | $39K | Sell |
233
-19,560
| -99% | -$3.27M | ﹤0.01% | 6046 |
|
|
2021
Q3 | $2.76M | Buy |
19,793
+19,394
| +4,861% | +$2.7M | ﹤0.01% | 2507 |
|
|
2021
Q2 | $190K | Sell |
399
-11
| -3% | -$5.24K | ﹤0.01% | 4368 |
|
|
2021
Q1 | $168K | Buy |
410
+320
| +356% | +$131K | ﹤0.01% | 4625 |
|
|
2020
Q4 | $44K | Sell |
90
-360
| -80% | -$176K | ﹤0.01% | 5303 |
|
|
2020
Q3 | $255K | Buy |
450
+415
| +1,186% | +$235K | ﹤0.01% | 3843 |
|
|
2020
Q2 | $3K | Sell |
35
-592
| -94% | -$50.7K | ﹤0.01% | 6685 |
|
|
2020
Q1 | $45K | Sell |
627
-1,391
| -69% | -$99.8K | ﹤0.01% | 5026 |
|
|
2019
Q4 | $139K | Buy |
2,018
+913
| +83% | +$62.9K | ﹤0.01% | 4810 |
|
|
2019
Q3 | $88K | Buy |
1,105
+1,040
| +1,600% | +$82.8K | ﹤0.01% | 4918 |
|
|
2019
Q2 | $4K | Sell |
65
-35
| -35% | -$2.15K | ﹤0.01% | 6579 |
|
|
2019
Q1 | $14K | Sell |
100
-59
| -37% | -$8.26K | ﹤0.01% | 5753 |
|
|
2018
Q4 | $15K | Buy |
159
+119
| +298% | +$11.2K | ﹤0.01% | 6070 |
|
|
2018
Q3 | $6K | Sell |
40
-100
| -71% | -$15K | ﹤0.01% | 6483 |
|
|
2018
Q2 | $24K | Buy |
140
+35
| +33% | +$6K | ﹤0.01% | 5653 |
|
|
2018
Q1 | $15K | Sell |
105
-25
| -19% | -$3.57K | ﹤0.01% | 5736 |
|
|
2017
Q4 | $26K | Hold |
130
| – | – | ﹤0.01% | 5389 |
|
|
2017
Q3 | $42K | Sell |
130
-124
| -49% | -$40.1K | ﹤0.01% | 5024 |
|
|
2017
Q2 | $57K | Sell |
254
-13
| -5% | -$2.92K | ﹤0.01% | 4649 |
|
|
2017
Q1 | $60K | Buy |
267
+112
| +72% | +$25.2K | ﹤0.01% | 4500 |
|
|
2016
Q4 | $31K | Sell |
155
-45
| -23% | -$9K | ﹤0.01% | 5278 |
|
|
2016
Q3 | $49K | Buy |
200
+112
| +127% | +$27.4K | ﹤0.01% | 4672 |
|
|
2016
Q2 | $51K | Sell |
88
-6
| -6% | -$3.48K | ﹤0.01% | 4654 |
|
|
2016
Q1 | $50K | Buy |
94
+41
| +77% | +$21.8K | ﹤0.01% | 4719 |
|
|
2015
Q4 | $38K | Buy |
+53
| New | +$38K | ﹤0.01% | 4979 |
|